4-(4-fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsulfonyl)amino]pyrimidine-5-methanol is a new generation of Statin blood lipid-lowering drugs, which belong to HMG-CoA reductase inhibitors, can reduce elevated low-density cholesterol, total cholesterol, triglyceride and apoenzyme-based protein ChemicalbookB concentrations, while increasing high-density cholesterol concentrations. It can be used for the comprehensive treatment of primary hypercholesterolemia, mixed lipodystrophy and homozygous familial hypercholesterolemia. Compared with other statin hypolipidemic drugs, rosuvastatin has the advantages of definite curative effect, convenient and safe use, and less side effects, so it is called "super statin".